Economy

Intercell develops novel vaccines including needle-free applications for the 21st century that prevent and treat infectious diseases and enable improved worldwide access to healthcare.

Intercell believes that economic success is linked to achieving ecological and social goals. This requires long-term thinking and decision-making. Lasting continuity in both thought and action is an important requirement in the complex and time-consuming process of developing vaccines.

Over the next several years, Intercell expects to strengthen its pipeline further by reinvesting revenue streams into R&D and to maintain its independence as a leading vaccine biotech company going forward. Our reputation for transforming innovation into products demonstrates the sustainability of our company and of the healthcare benefits we deliver.